Bensimidazoler
- (3)
- (3)
- (2)
- (1)
- (9)
- (3)
- (2)
- (4)
- (3)
- (3)
- (3)
- (3)
- (3)
- (3)
- (6)
- (2)
- (3)
- (3)
- (9)
- (1)
- (2)
- (3)
- (5)
- (3)
- (3)
- (3)
- (3)
- (5)
- (3)
- (3)
- (6)
- (6)
- (3)
- (11)
- (2)
- (2)
- (1)
- (9)
- (7)
- (2)
- (23)
- (1)
- (17)
- (6)
- (1)
- (19)
- (4)
- (2)
- (16)
- (1)
- (19)
- (6)
- (3)
- (60)
- (1)
- (3)
Filtrerade sökresultat
Thermo Scientific Chemicals Omeprazol, 98+%
CAS: 73590-58-6 Molekylformel: C17H19N3O3S Molekylvikt (g/mol): 345.42 InChI-nyckel: SUBDBMMJDZJVOS-UHFFFAOYSA-N Synonym: omeprazole,losec,prilosec,antra,esomeprazole,omeprazon,audazol,omapren,omepral,parizac PubChem CID: 4594 ChEBI: CHEBI:77260 IUPAC-namn: 6-metoxi-2-[(4-metoxi-3,5-dimetylpyridin-2-yl)metylsulfinyl]-lH-bensimidazol LEDER: CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC
| Molekylformel | C17H19N3O3S |
|---|---|
| PubChem CID | 4594 |
| IUPAC-namn | 6-metoxi-2-[(4-metoxi-3,5-dimetylpyridin-2-yl)metylsulfinyl]-lH-bensimidazol |
| CAS | 73590-58-6 |
| InChI-nyckel | SUBDBMMJDZJVOS-UHFFFAOYSA-N |
| LEDER | CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC |
| ChEBI | CHEBI:77260 |
| Molekylvikt (g/mol) | 345.42 |
| Synonym | omeprazole,losec,prilosec,antra,esomeprazole,omeprazon,audazol,omapren,omepral,parizac |
(S)-(-)-Pantoprazol natriumsalt, TRC
CAS: 160488-53-9 Molekylformel: C16 H14 F2 N3 O4 S . Na Molekylvikt (g/mol): 405.35 Synonym: 1H-Benzimidazole, 6-(difluoromethoxy)-2-[(S)-[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1),1H-Benzimidazole, 5-(difluoromethoxy)-2-[(S)-[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (9CI),(S)-(-)-Pantoprazole sodium salt IUPAC-namn: sodium;5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide LEDER: [Na+].COc1ccnc(C[S@](=O)c2nc3cc(OC(F)F)ccc3[n-]2)c1OC
| Molekylformel | C16 H14 F2 N3 O4 S . Na |
|---|---|
| IUPAC-namn | sodium;5-(difluoromethoxy)-2-[(S)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide |
| CAS | 160488-53-9 |
| LEDER | [Na+].COc1ccnc(C[S@](=O)c2nc3cc(OC(F)F)ccc3[n-]2)c1OC |
| Molekylvikt (g/mol) | 405.35 |
| Synonym | 1H-Benzimidazole, 6-(difluoromethoxy)-2-[(S)-[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1),1H-Benzimidazole, 5-(difluoromethoxy)-2-[(S)-[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (9CI),(S)-(-)-Pantoprazole sodium salt |
Pantoprazol natriumsalthydrat
CAS: 718635-09-7 Molekylformel: C16H14F2N3NaO4S Molekylvikt (g/mol): 405.35 MDL-nummer: MFCD08704580 InChI-nyckel: YNWDKZIIWCEDEE-UHFFFAOYNA-N Synonym: pantoprazole sodium,pantoprazole sodium hydrate,pantozol hydrate,protonix hydrate,c16h14f2n3nao4s.h2o,sodium pantoprazole 1-hydrate,pantoprazole sodium hydrate hplc,5-difluoromethoxy-2-3,4-dimethoxypyridin-2-yl methanesulfinyl-1-sodio-1,3-benzodiazole hydrate,5-difluoromethoxy-2-3,4-dimethoxy-2-pyridinyl methyl sulfinyl-1h-benzimidazole sodium salt hydrate PubChem CID: 23684923 IUPAC-namn: natrium;5-(difluormetoxi)-2-[(3,4-dimetoxipyridin-2-yl)metylsulfinyl]bensimidazol-l-id;hydrat LEDER: [Na+].COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3[N-]2)=NC=C1
| Molekylformel | C16H14F2N3NaO4S |
|---|---|
| PubChem CID | 23684923 |
| MDL-nummer | MFCD08704580 |
| IUPAC-namn | natrium;5-(difluormetoxi)-2-[(3,4-dimetoxipyridin-2-yl)metylsulfinyl]bensimidazol-l-id;hydrat |
| CAS | 718635-09-7 |
| InChI-nyckel | YNWDKZIIWCEDEE-UHFFFAOYNA-N |
| LEDER | [Na+].COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3[N-]2)=NC=C1 |
| Molekylvikt (g/mol) | 405.35 |
| Synonym | pantoprazole sodium,pantoprazole sodium hydrate,pantozol hydrate,protonix hydrate,c16h14f2n3nao4s.h2o,sodium pantoprazole 1-hydrate,pantoprazole sodium hydrate hplc,5-difluoromethoxy-2-3,4-dimethoxypyridin-2-yl methanesulfinyl-1-sodio-1,3-benzodiazole hydrate,5-difluoromethoxy-2-3,4-dimethoxy-2-pyridinyl methyl sulfinyl-1h-benzimidazole sodium salt hydrate |
Albendazol, 98+%
CAS: 54965-21-8 Molekylformel: C12H15N3O2S Molekylvikt (g/mol): 265.33 MDL-nummer: MFCD00083232 InChI-nyckel: HXHWSAZORRCQMX-UHFFFAOYSA-N Synonym: albendazole,albenza,eskazole,valbazen,zentel,albendazol,proftril,albendazolum,bilutac,zental PubChem CID: 2082 ChEBI: CHEBI:16664 IUPAC-namn: metyl N-(6-propylsulfanyl-lH-bensimidazol-2-yl)karbamat LEDER: CCCSC1=CC=C2N=C(NC(=O)OC)NC2=C1
| Molekylformel | C12H15N3O2S |
|---|---|
| PubChem CID | 2082 |
| MDL-nummer | MFCD00083232 |
| IUPAC-namn | metyl N-(6-propylsulfanyl-lH-bensimidazol-2-yl)karbamat |
| CAS | 54965-21-8 |
| InChI-nyckel | HXHWSAZORRCQMX-UHFFFAOYSA-N |
| LEDER | CCCSC1=CC=C2N=C(NC(=O)OC)NC2=C1 |
| ChEBI | CHEBI:16664 |
| Molekylvikt (g/mol) | 265.33 |
| Synonym | albendazole,albenza,eskazole,valbazen,zentel,albendazol,proftril,albendazolum,bilutac,zental |
N-[3-metyl-4-(2,2,2-trifluoretoxi)-2-pyridinyl]metyllansoprazol, TRC
CAS: 1083100-26-8 Molekylformel: C25H22F6N4O3S Molekylvikt (g/mol): 572.52 Synonym: 1-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole,Lansoprazole Impurity IUPAC-namn: 1-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]-2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]benzimidazole LEDER: Cc1c(OCC(F)(F)F)ccnc1CS(=O)c2nc3ccccc3n2Cc4nccc(OCC(F)(F)F)c4C
| Molekylformel | C25H22F6N4O3S |
|---|---|
| IUPAC-namn | 1-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]-2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]benzimidazole |
| CAS | 1083100-26-8 |
| LEDER | Cc1c(OCC(F)(F)F)ccnc1CS(=O)c2nc3ccccc3n2Cc4nccc(OCC(F)(F)F)c4C |
| Molekylvikt (g/mol) | 572.52 |
| Synonym | 1-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole,Lansoprazole Impurity |
6-(Difluorometoxi)-2-[[(3,4-dimetoxi-2-pyridinyl)metyl]-1-metyl-1H-benzimidazol, TRC
CAS: 721924-06-7 Molekylformel: C17H17F2N3O4S Molekylvikt (g/mol): 397.4 Synonym: Pantoprazole EP Impurity LEDER: COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3n2C)c1OC
| Molekylformel | C17H17F2N3O4S |
|---|---|
| CAS | 721924-06-7 |
| LEDER | COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3n2C)c1OC |
| Molekylvikt (g/mol) | 397.4 |
| Synonym | Pantoprazole EP Impurity |
4-Desmetoxi-4-kloro Omeprazol, TRC
CAS: 863029-89-4 Molekylformel: C16 H16 Cl N3 O2 S Molekylvikt (g/mol): 349.84 Synonym: 2-[(RS)-[(4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole,Omeprazole Imp. H (EP) IUPAC-namn: 2-[(4-chloro-3,5-dimethylpyridin-2-yl)methylsulfinyl]-5-methoxy-1H-benzimidazole LEDER: COc1ccc2[nH]c(nc2c1)S(=O)Cc3ncc(C)c(Cl)c3C
| Molekylformel | C16 H16 Cl N3 O2 S |
|---|---|
| IUPAC-namn | 2-[(4-chloro-3,5-dimethylpyridin-2-yl)methylsulfinyl]-5-methoxy-1H-benzimidazole |
| CAS | 863029-89-4 |
| LEDER | COc1ccc2[nH]c(nc2c1)S(=O)Cc3ncc(C)c(Cl)c3C |
| Molekylvikt (g/mol) | 349.84 |
| Synonym | 2-[(RS)-[(4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole,Omeprazole Imp. H (EP) |
Pantoprazol N-oxid, TRC
CAS: 953787-60-5 Molekylformel: C16 H15 F2 N3 O5 S Molekylvikt (g/mol): 399.37 Synonym: Pantoprazole N-Oxide,6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-1-oxido-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole IUPAC-namn: 5-(difluorometoxi)-2-[(3,4-dimetoxi-1-oxidopyridin-1-ium-2-yl)metylsulfinyl]-1H-benzimidazol LEDER: COc1cc[n+]([O-])c(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC
| Molekylformel | C16 H15 F2 N3 O5 S |
|---|---|
| IUPAC-namn | 5-(difluorometoxi)-2-[(3,4-dimetoxi-1-oxidopyridin-1-ium-2-yl)metylsulfinyl]-1H-benzimidazol |
| CAS | 953787-60-5 |
| LEDER | COc1cc[n+]([O-])c(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC |
| Molekylvikt (g/mol) | 399.37 |
| Synonym | Pantoprazole N-Oxide,6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-1-oxido-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole |
N-metyl pantoprazol (blandning av 1 och 3 isomerer), TRC
CAS: 624742-53-6 Molekylformel: C17 H17 F2 N3 O4 S Molekylvikt (g/mol): 397.4 Synonym: 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1-methyl-1H-Benzimidazole,Pantoprazole Sodium Sesquihydrate Imp. D (EP) IUPAC-namn: 5-(difluorometoxi)-2-[(3,4-dimetoxypyridin-2-yl)metylsulfinyl]-1-metylbensimidazol LEDER: COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3n2C)c1OC
| Molekylformel | C17 H17 F2 N3 O4 S |
|---|---|
| IUPAC-namn | 5-(difluorometoxi)-2-[(3,4-dimetoxypyridin-2-yl)metylsulfinyl]-1-metylbensimidazol |
| CAS | 624742-53-6 |
| LEDER | COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3n2C)c1OC |
| Molekylvikt (g/mol) | 397.4 |
| Synonym | 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1-methyl-1H-Benzimidazole,Pantoprazole Sodium Sesquihydrate Imp. D (EP) |
Lansoprazol, TRC
CAS: 103577-45-3 Molekylformel: C16 H14 F3 N3 O2 S Molekylvikt (g/mol): 369.36 Synonym: Lansoprazole,(±)-Lansoprazole,2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole,A 65006,AG 1749,Agopton,Ilsatec,Ketian,Lancid,Lanfast,Lanproton,Lansopep,Lansophed,Lanston,Lanz,Lanzol 30,Lanzopral,Lanzor,Lapraz,Ogast,Ogastro,PP/K-10,Prevacid,Promp,Prosogan,Suprecid,Takepron,Ulpax,Zoton IUPAC-namn: 2-[[3-metyl-4-(2,2,2-trifluoretoxi)pyridin-2-yl]metylsulfinyl]-1H-benzimidazol LEDER: Cc1c(OCC(F)(F)F)ccnc1CS(=O)c2nc3ccccc3[nH]2
| Molekylformel | C16 H14 F3 N3 O2 S |
|---|---|
| IUPAC-namn | 2-[[3-metyl-4-(2,2,2-trifluoretoxi)pyridin-2-yl]metylsulfinyl]-1H-benzimidazol |
| CAS | 103577-45-3 |
| LEDER | Cc1c(OCC(F)(F)F)ccnc1CS(=O)c2nc3ccccc3[nH]2 |
| Molekylvikt (g/mol) | 369.36 |
| Synonym | Lansoprazole,(±)-Lansoprazole,2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole,A 65006,AG 1749,Agopton,Ilsatec,Ketian,Lancid,Lanfast,Lanproton,Lansopep,Lansophed,Lanston,Lanz,Lanzol 30,Lanzopral,Lanzor,Lapraz,Ogast,Ogastro,PP/K-10,Prevacid,Promp,Prosogan,Suprecid,Takepron,Ulpax,Zoton |
Rabeprazolnatriumsalt, TRC
CAS: 117976-90-6 Molekylformel: C18 H20 N3 O3 S . Na Molekylvikt (g/mol): 381.42 Synonym: 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1),1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (9CI),2-[[[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methyl]sulfinyl]-1H-benzimidazole sodium salt,Aciphex,E 3810,LY 307640 sodium,Pariet,Pariprazole,Pepcia,Rabeprazole sodium,Rabicip,Razo IUPAC-namn: natrium; 2-[[4-(3-metoxipropoxi)-3-metylpyridin-2-yl]metylsulfinyl]benzimidazol-1-ide LEDER: [Na+].COCCCOc1ccnc(CS(=O)c2nc3ccccc3[n-]2)c1C
| Molekylformel | C18 H20 N3 O3 S . Na |
|---|---|
| IUPAC-namn | natrium; 2-[[4-(3-metoxipropoxi)-3-metylpyridin-2-yl]metylsulfinyl]benzimidazol-1-ide |
| CAS | 117976-90-6 |
| LEDER | [Na+].COCCCOc1ccnc(CS(=O)c2nc3ccccc3[n-]2)c1C |
| Molekylvikt (g/mol) | 381.42 |
| Synonym | 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (1:1),1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-, sodium salt (9CI),2-[[[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methyl]sulfinyl]-1H-benzimidazole sodium salt,Aciphex,E 3810,LY 307640 sodium,Pariet,Pariprazole,Pepcia,Rabeprazole sodium,Rabicip,Razo |
(R)-omeprazolnatriumsalt, TRC
CAS: 161796-77-6 Molekylformel: C17 H18 N3 O3 S . Na Molekylvikt (g/mol): 367.4 Synonym: 6-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt (1:1),1H-Benzimidazole, 5-methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (9CI),1H-Benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt, (R)-,(R)-Omeprazole sodium IUPAC-namn: natrium; 5-metoxi-2-[(R)-(4-metoxi-3,5-dimetylpyridin-2-yl)metylsulfinyl]benzimidazol-1-ide LEDER: [Na+].COc1ccc2[n-]c(nc2c1)[S@](=O)Cc3ncc(C)c(OC)c3C
| Molekylformel | C17 H18 N3 O3 S . Na |
|---|---|
| IUPAC-namn | natrium; 5-metoxi-2-[(R)-(4-metoxi-3,5-dimetylpyridin-2-yl)metylsulfinyl]benzimidazol-1-ide |
| CAS | 161796-77-6 |
| LEDER | [Na+].COc1ccc2[n-]c(nc2c1)[S@](=O)Cc3ncc(C)c(OC)c3C |
| Molekylvikt (g/mol) | 367.4 |
| Synonym | 6-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt (1:1),1H-Benzimidazole, 5-methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (9CI),1H-Benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt, (R)-,(R)-Omeprazole sodium |
5-hydroxyomeprazol (~5 % trietylamin som stabilisator), TRC
CAS: 92340-57-3 Molekylformel: C17H19N3O4S Molekylvikt (g/mol): 361.42 Synonym: 3-Pyridinemethanol, 4-methoxy-6-[[(6-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-5-methyl-,[4-methoxy-6-[(5-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-5-methyl-3-pyridyl]methanol,5'-Hydroxyomeprazole IUPAC-namn: [4-metoxi-6-[(5-metoxi-1H-benzimidazol-2-yl)sulfinylmetyl]-5-metylpyridin-3-yl]metanol LEDER: COc1ccc2[nH]c(nc2c1)S(=O)Cc3ncc(CO)c(OC)c3C
| Molekylformel | C17H19N3O4S |
|---|---|
| IUPAC-namn | [4-metoxi-6-[(5-metoxi-1H-benzimidazol-2-yl)sulfinylmetyl]-5-metylpyridin-3-yl]metanol |
| CAS | 92340-57-3 |
| LEDER | COc1ccc2[nH]c(nc2c1)S(=O)Cc3ncc(CO)c(OC)c3C |
| Molekylvikt (g/mol) | 361.42 |
| Synonym | 3-Pyridinemethanol, 4-methoxy-6-[[(6-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-5-methyl-,[4-methoxy-6-[(5-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-5-methyl-3-pyridyl]methanol,5'-Hydroxyomeprazole |